SLG Firm News
Read below for important news.
Judge Frank Geraci, Jr.’s Decision
New York federal court denies motion to dismiss (in part) and permits SLG’s client, Mimetogen Pharmaceuticals, Inc., to pursue extra-contractual damages outside of contractual limitation on liability in breach of contract claim against Bausch & Lomb Incorporated,...
Former Harmonix Stockholders Defeat Viacom International’s Motion to Dismiss
Former Harmonix Stockholders Defeat Viacom International’s Motion to Dismiss; Judge Rules that Case May Proceed. Read Judge Eric M. Davis’s Opinion regarding SLG client, Walter Winshall, representing former Harmonix Stockholders, here.
David Shlansky, Esq., quoted in Financial Post Article
Bausch & Lomb Incorporated v. Mimetogen Pharmaceuticals Inc.: David Shlansky, Esq., quoted in Financial Post article regarding SLG’s client, Mimetogen Pharmaceuticals Inc., and its dispute with Bausch & Lomb Incorporated. Read “The behemoth, the biotech and...
Client Update: SLG’s Colin Hagan recently completed an extensive examination of the “Manager Rule” and has compiled his findings in the article titled ‘”Manager Rule” Not the Rule in Fourth Circuit.’ Read the full article here.
Massachusetts Office Has Moved
SLG is pleased to announce that our Massachusetts office has moved! Located at 1 Winnisimmet Street, in Chelsea, our new office offers more space and improved accessibility to better serve our growing client base.
David Shlansky, quoted on Bloomberg.com’s Apple-Samsung article.
SLG Managing Partner, David Shlansky, was quoted on Bloomberg.com’s Apple-Samsung article. Read the article, including David’s commentary, here.